Here’s why you should hold Myriad Genetics (MYGN) Stock now

Zacks Investment Research

A myriad of genetics (MYGN Quick quoteMYGN – Free Report) is well-prepared for growth in the coming quarters, supported by the strength of its oncology business. The company has launched a number of products in recent months. Progress in its transformation plan, growth initiatives and planned divestitures will provide MYGN with a foundation for continued … Read more

CENTOGENE and Lifera, a PIF-Owned Biopharmaceutical Company, Enter Strategic Collaboration – Forming Joint Venture in Saudi Arabia to Increase Access to Leading Data-Driven Multiomics Testing and Secure $30 Million Investment for CENTOGENE

Centogene NV

Centogene NV Joint Venture (JV) combines CENTOGENE’s global leadership in multiomics with the local knowledge of Lifera, a biopharmaceutical company wholly owned by the Public Investment Fund (PIF) based in Riyadh JV focuses on providing state-of-the-art multiomics testing services to patients, healthcare systems, biopharmaceutical customers and research institutions in Saudi Arabia and the Gulf Cooperation … Read more